Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Uganda still struggling to tackle Ebola as the death toll passes 50

Health authorities in Uganda are struggling to contain the Ebola virus after reporting 51 deaths, including healthcare workers and 132 cases across seven districts in the country. While some government-instituted lockdowns have been put in place, the International Rescue Committee is calling for more funding to curb the spread of…

Radio France Internationale

3 Biotech Stocks to Accumulate During the Bear Market

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider.

StockNews.com

Ebola spreads despite lockdown as death toll of killer virus passes 50

Covid-style lockdowns have been extended in Uganda with more than 50 deaths reported since the start of the outbreak.

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Confidence in vaccines plummets since start of Covid-19 pandemic

The fall is across the board and comes regardless of age, gender, religious belief, education or ethnicity

Wales Online

Long Covid sufferers still battling with virus three years on from getting infected

More than two million people in the UK are believed to have Long Covid, with the longest sufferers said to have fallen ill with the virus before the pandemic began

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

Pfizer’s Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long COVID, a study found.

Tribune News Service

A united front in fight against the 'silent pandemic'

Antimicrobial resistance is one of the biggest public health challenges of our time and we’re at a crossroads on how to combat it.

360info

Former Petrobras executive asks Brazil court to block dividend payment

Guilherme Estrella, former director of Brazil's state-controlled oil giant Petrobras, filed a lawsuit in court to block the payment of dividends by the company. In a late Friday filing, Petrobras reported that Estrella, a former director of exploration and production, requested the blocking of 32.1 billion reais ($6.6 billion) in…

Reuters

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Irish pharmacies running low on vital diabetes drug after viral TikTok video reveals weight loss benefits

Hundreds of videos followed with people explaining how the injectables can be used for effective weight loss when prescribed by a GP

Irish Mirror

These companies claim to support abortion rights. They are backing anti-abortion Republicans

An analysis of major companies’ donations, including Meta and Amazon, reveals donations to candidates calling for banning the procedure

The Guardian - US

China posts 6-month high COVID count as it sticks with strategy

China on Sunday reported its highest number of new COVID-19 infections in six months, a day after health officials said they were sticking with strict coronavirus curbs, likely disappointing recent investor hopes for an easing.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

Newcastle Herald

The COVID drug under a cloud that made billions

'It's a big deal because the Australian government purchased a huge amount of that drug.'

Tribune News Service

Regeneron, Bayer offer more promising data for aging eye drug

Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.

Daily Mirror

NHS could pay higher drug prices if Brexit trade deal with India goes ahead

India supplies the NHS with a quarter of its medicines and changes to pharma monopoly rights and patent laws under leaked plans could see costs spiral

Wales Online

Public's confidence in vaccines plummets since Covid pandemic

Covid vaccines are estimated to have saved tens of millions of lives during the pandemic

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

Bangkok Post

Speed pill prices plunge to B2 each

Methamphetamine pills, which cost as much as 300 baht apiece in Thailand just a few years ago, can now be had for as little as two baht each, say police who arrested a drug suspect in Lop Buri.

Benzinga

Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).

Benzinga

LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress

Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its

The Independent UK

High court to hear water dispute between Navajo, government

The Supreme Court will hear a water dispute involving the U.S. government and the Navajo Nation

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Salon

An epidemic of fentanyl misinformation

More politicians say fentanyl should be deemed a "weapon of mass destruction." Do they even understand what it is?

1 … 106 107 108 109

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations